Comparing two cardioversion methods for persistent AFib
Part of Heart & circulation clinical trials.
This trial compares two ways of doing cardioversion (a procedure to restore normal heart rhythm) for people with persistent atrial fibrillation. It aims to see if one approach leads to a better recovery and fewer complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have persistent atrial fibrillation (a long-lasting irregular heartbeat).
- You are scheduled for a cardioversion (a procedure to reset your heart rhythm) at the University of Ottawa Heart Institute.
- You do not have a known blood clot in your heart.
- You are able to take blood thinners safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether one ablation approach works better than another for paroxysmal (intermittent) atrial fibrillation by targeting the heart’s “triggers” and “substrate” (where the rhythm problem is). If you qualify, you’ll be randomly assigned to one of two ablation energy methods during a pulmonary vein isolation procedure.
This trial tests whether using a specific “shock energy” during electrical cardioversion works safely and effectively for people with persistent atrial fibrillation. You might be eligible if your cardioversion is planned (not an emergency) and your doctors determine you can safely take blood thinners.
This study looks at how a heart rhythm procedure (cardioversion) affects quality of life in people with persistent atrial fibrillation (AF). It may help you understand whether a specific approach can improve day-to-day symptoms and well-being after treatment.
This trial tests a new method using two electrical shocks to help restore a normal heart rhythm in patients with persistent atrial fibrillation (a condition where the heart's upper chambers beat irregularly). The goal is to see if this technique is safe and effective.
This study compares three approaches to treat persistent atrial fibrillation (AF) that lasts more than 7 days. It tests whether isolating the pulmonary veins alone is enough, or if also targeting low-voltage areas (scarred heart tissue) during either normal rhythm or AF works better.
This study compares two different catheters that use pulsed field ablation to treat a type of irregular heartbeat called persistent atrial fibrillation. The goal is to see which one works better and is safer.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.